Safety and Feasibility of Infliximab Therapy in Children With Kawasaki Disease Who Received Live Vaccinations. Ohnishi Y, Okada S, Kawakami-Miyake A, Furuta T, et al. Pediatr Infect Dis J 2022 Jul 27. pii: 00006454-990000000-00145.

Read + Share

Amedeo Smart

Independent Medical Education

Ohnishi Y, Okada S, Kawakami-Miyake A, Furuta T, et al. Safety and Feasibility of Infliximab Therapy in Children With Kawasaki Disease Who Received Live Vaccinations. Pediatr Infect Dis J 2022 Jul 27. pii: 00006454-990000000-00145.
PMID: 35895884